Nordic Tech List
Nordic Tech List uses cookies to improve your experience and so you don't have to see this annoying banner every time you visit the site. By continuing to use the site you accept the use of cookies. More information about cookies
OxThera
euro_symbol
Looking for funding: Unknown
arrow_forward
Unknown revenue growth
business
Company
Sweden

OxThera

OxThera is a biopharmaceutical company with products in late stage clinical development focusing on Primary and Secondary Hyperoxaluria. OxThera’s intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria, and enzymes. Oxabact® holds Orphan Drug designations in Europe and in the US for the treatment of primary hyperoxaluria. CEO is Elisabeth Lindner.

Edit organization
9 June 2005
5566815667
5
Sturegatan 56, 114 36 Stockholm, Sweden
?

Funding

Funding Received
€38M
Funding rounds
2
Investors
2
Investors & Shareholderschevron_left
Investmentschevron_left

Connections

Add connection to OxThera

Timeline

2018
2017
  • Funding €6M (November)
2016
  • Funding €32M (November)
2005 - Founded

Exit

No exit added
Add exit

Top contributors


Nordic Tech List Bot
Nordic Tech List Bot automatically looks for new data on all profiles with a organization number
54 contributions
sara-mattsson
11 contributions
Nordic Tech List Editor
Nordic Tech List Editor is manually updating profiles with the latest data
9 contributions
NTL Bulk Data Editor
NTL Bulk Data Editor doesn't have a profile yet
1 contributions

The content of this page is partly user generated and not controlled by the Nordic Tech List editorial team, nor is it part of the Nordic Tech List editorial database: Nordictechlist.com. For more info see FAQ.